Tetraphase Pharma (TTPH) Misses Q4 EPS by 6c

Tetraphase Pharma (NASDAQ: TTPH) reported Q4 EPS of ($0.50), $0.06 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.47 million versus the consensus estimate of $3.23 million.

For earnings history and earnings-related data on Tetraphase Pharma (TTPH) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright